EDGAR Filing Documents for 0001140361-23-049322

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001140361-23-049322

Filing Date

2023-10-24

Accepted

2023-10-24 16:08:01

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3/A	ny20009756x4_s3a.htm	S-3/A	420763
2	EXHIBIT 23.1	ny20009756x4_ex23-1.htm	EX-23.1	2351
3	EXHIBIT 23.2	ny20009756x4_ex23-2.htm	EX-23.2	1881
4		logo_catalystbio.jpg	GRAPHIC	40022
5		logo_catalystbiox1.jpg	GRAPHIC	70509
	Complete submission text file	0001140361-23-049322.txt		577935

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761

CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-273395 | Film No.: 231342797
SIC: 2834 Pharmaceutical Preparations